Profound Medical signs exclusive distribution deal for TULSA-PRO in Australia, New Zealand

Profound Medical Corp.

Exclusive distribution & supply agreement with Getz Healthcare for TULSA-PRO system in Australia and New Zealand.
TULSA-PRO is an AI-powered, MRI-guided robotic system for real-time prostate ablation without surgery or radiation.
Partnership leverages Getz Healthcare's established distribution network in the region.
Profound also deploys direct sales in North America while partnering with strategic distributors internationally.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.